Сytokine profile of blood plasma in acute pyelonephritis at different trimesters of gestation



Cite item

Full Text

Abstract

Among bacterial infections that threat female health and life, urinary tract infections (UTI) take a leading position among reasons for hospitalization and the development of negative reactions during pregnancy. The fundamental importance for the onset and end of acute pyelonephritis is given to the state of the innate link of immunity. A special role in the formation of the “cytokine cascade” belongs to various types of cytokines. An increased incidence of pyelonephritis in pregnant women shows insufficient awareness, as well as a lack of understanding various aspects of the pathogenesis in this disease, especially regarding cytokine status of pregnant women at the local and systemic levels. The aim of our work was to study the dynamics of cytokine profile in peripheral blood plasma in acute pyelonephritis at different trimesters of pregnancy before and after treatment. Materials and methods: The study included 143 women (mean age 25.3±5.2 years), divided into different groups. I.e., comparison group included healthy non-pregnant women and women with physiological pregnancy in the 1st , 2nd, and 3rd trimesters without kidney pathology; main group consisted of pregnant women with acute serous pyelonephritis in the 1st , 2nd and 3rd trimesters of pregnancy, as well as two groups of women with acute pyelonephritis in the 2nd and 3rd trimesters of gestation with basic treatment including the immunomodulator Viferon, or without this medication. The dynamics of changes in the cytokine profile before and after treatment were studied in the samples of peripheral blood plasma. Results: In acute serous pyelonephritis, the cytokine content at the systemic level was increased, in the course of pregnancy, especially, over 2nd and 3rd trimesters, thus suggesting the presence of immune inflammation. The basic treatment does not fully normalize the altered parameters of cytokine profile, mainly in the 2nd and 3rd trimesters of gestation. The best corrective effect is achieved by pharmacotherapy with the addition of Viferon to the basic treatment. The results of this work expand the existing views on the participation of cytokines in pathogenesis of acute pyelonephritis during different trimesters of pregnancy.

About the authors

Ivan Mikhailovich Kholimenko

Kursk Regional Multidisciplinary Clinical Hospital, Kursk, Russian Federation

Email: kholimenko@yandex.ru
ORCID iD: 0000-0003-2945-6821
SPIN-code: 6450-2444

Ph.D. in Medicine

Russian Federation, Kursk region, Kursk city, Sumskaya street 45a.

Maxim Nikolaevich Shatokhin

Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation

Email: sh.77@mail.ru
ORCID iD: 0000-0002-1285-7357
SPIN-code: 7344-9309

Professor, Professor of the Department of Endoscopic Urology of Russian Medical Academy of Postgraduated Education

Russian Federation, 125993, Moscow, Russian Federation;

Alexey Alexandrovich Konoplya

Limited Liability Company "STOMED" Medical Center, Moscow, Russian Federation

Email: kanabis03101980@yandex.ru
ORCID iD: 0000-0001-5040-7499
SPIN-code: 2766-8468

Doctor of Medical Sciences, Associate Professor, Head of the Department of Obstetrics and Gynecology

Russian Federation, 140000, Moscow, Russian Federation;

Irina Valentinovna Evsegneeva

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

Email: ivevsegneeva@yandex.ru
ORCID iD: 0000-0002-6624-1363
SPIN-code: 6467-4120

Doctor of Medical Sciences, Professor, Department of Clinical Immunology and Allergology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University

Russian Federation, 119991, Moscow, Russian Federation.

Mikhail Yuryevich Mavrin

Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation

Author for correspondence.
Email: dr.mavrin@mail.ru
ORCID iD: 0009-0003-2562-1495
SPIN-code: 7096-2610

Candidate of Medical Sciences. Urologist. Department of Endoscopic Urology, Federal State Budgetary Educational Institution of Higher Professional Education, Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation;

Russian Federation, 125993, Moscow, Russian Federation;

References

  1. Stepankova E.A., Sukhorukova A.O. Pyelonephritis and pregnancy. Difficult patient, 2021, Vol. 1, no.9, pp. 27-30.
  2. Laukhtina E.A., Enikeev D.V., Shpikina A.D., Inoyatov Zh.Sh., Taratkin M.S., Alyaev YuG. Modern aspects of the diagnosis of pyelonephritis in pregnant women. Issues of urology and andrology, 2020, Vol. 8, no.2, pp. 5-10.
  3. -
  4. Kogan M.I. Pyelonephritis during pregnancy (chief editor's opinion on the problem). Urology Bulletin, 2020, Vol. 8, no.2, pp. 5-9.
  5. Kligunenko E.N., Volkov A.O. The ratio of pro- and anti-inflammatory cytokines in pregnant women in the third trimester. Emergency Medicine, 2014, Vol. 7, no.62, pp. 131-133.
  6. -
  7. Oskolkov S.A., Zhmurov V.A., Sinyaev E.A., Petrov I.M., Paketov S.A., Zhmurov D.V. The role of pro-inflammatory cytokines in the pathogenesis of secondary chronic pyelonephritis against the background of nephrolithiasis. Medical Science and Education of the Urals, 2018, Vol. 19, no.2, pp. 24-27.
  8. Pavlyuchenko I.I., Bezrukova O.S., Zobenko V.Y., Esauenko E.E., Basov A.A., Storozhuk A.P. The state of the antioxidant defense system and the cytokine profile of the blood at different stages of physiologically proceeding pregnancy. Crimean Journal of Experimental and Clinical Medicine, 2020, Vol. 10, no.2, pp. 40-47.
  9. Kligunenko E.N., Volkov A.O. The ratio of pro- and anti-inflammatory cytokines in pregnant women in the third trimester. Emergency Medicine, 2013, Vol. 6, no.53, pp. 162-164.
  10. Kolesnikova N.V. Cytokine status of pregnant women with chronic fetoplacental insufficiency (literature review). Russian Journal of Immunology, 2010, Vol. 11, no.4.13, pp. 43-351.
  11. Nefedova D.D., Linde V.A., Levkovich M.A. Immunological aspects of pregnancy (literature review). Medical Bulletin of the South of Russia, 2013, no.1, pp 16-21.
  12. -
  13. Lyashenko E.N., Aramyan E.E., Zinchenko M.S. "Cytokine storm" as an immunopathological reaction in pregnant women in the first trimester. Russian Bulletin of Obstetrician-Gynecologist, 2024, Vol. 24, no.5, pp. 19-24.
  14. Korenkov D.G., Pavlov A.L. Cytokines in determining the severity of the active phase of chronic pyelonephritis. Bulletin of Urology, 2017, Vol. 5, no.3, pp. 14-21.
  15. Zakharova N.B., Lyakh R.V., Druzhinina Yu.G., Ofitserov V.I. Cytokines in the urine of patients with acute pyelonephritis before and after treatment. Medical Immunology, 2017, Vol. 19, no.S, pp. 305.
  16. -
  17. Sumerkina V.A., Telesheva L.F., Golovneva E.S. Association of changes in the cytokine profile and components of metabolic syndrome in young patients. Russian Journal of Immunology, 2022, Vol. 25, no.1, pp. 535-540.
  18. Makarova T.P., Ishbuldina A.V. The role of cytokines in the progression of chronic kidney disease in children. Russian Bulletin of Perinatology and Pediatrics, 2021, Vol. 66, no.4, pp. 25-31.
  19. Karpina N.S., Nikulicheva V.I., Vagapova DR, Germash EI. Cytokine content in blood serum and urine of patients with chronic pyelonephritis. Medical Bulletin of the Ministry of Internal Affairs, 2015, Vol. 6, no.79, pp. 20-24.
  20. Belokrinitskaya T.E., Frolova N.I., Vyzhlova E.N., Malinovskaya V.V. Interferons during pregnancy. Obstetrics and Gynecology, 2024, no.2, pp. 144-150.
  21. Kosenkova T.V., Zazerskaya I.E., Klikunova K.A. Treatment of urogenital infections in pregnant women and intrauterine infection in newborns with recombinant interferon alpha-26 preparations: results of a meta-analysis. Issues of Gynecology. Obstetrics and Perinatology, 2020, Vol. 19, no.4, pp. 110-137.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Kholimenko I.M., Shatokhin M.N., Konoplya A.A., Evsegneeva I.V., Mavrin M.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.